Poppins

Based in Palaiseau, France, and founded in 2018, Bmotion Technologies SAS, trading under the name Poppins, spun out of the École Polytechnique, and operates as a medical equipment manufacturer specializing in music-based rehabilitation devices. Some of the firm’s clients include FFDys, CHU Poitiers, Neurodys PACA, Children’s Hospital Los Angeles, etc. In October 2023, the firm raised EUR 8 million in venture funding led by investor Eurazeo, with participation from other investors Allianz France, HEP Paris, Verve Ventures, BNP Paribas Développement, Bpifrance, and Kurma Partners. The firm, as of October 2023, is led by its Scientific Officer, Mélanie Descamps.

The company offers a program dedicated to supporting children facing learning disabilities like dyslexia, rebuilding their confidence, and facilitating a tailored care path. The company’s platform serves as a game-based learning companion that provides a supportive community for children and parents alike. The range of Poppins products includes a Therapeutic Program, that guides children through personalized exercises, including games to enhance reading, writing, and comprehension skills, as well as clinically validated musical games designed for children aged 7 to 11. The other programs include Complete Parental Monitoring, a platform that allows parents to track their child's progress, and manage screen time, and includes regular telephone follow-up, fostering a comprehensive approach to learning support and support community called The Poppins Club offering a wide range of learning disability resources, direct access to health experts, and a community where parents can share their experiences and support one another.

The company plans to utilize the October 2023 funding to launch its digital therapeutic program on a large scale and to expand its research and clinical study initiative.